Assessment of Utility of accelerateIQ in the Care of Patients Participating in a Pulmonary Rehabilitation Program



Status:Enrolling by invitation
Conditions:Chronic Obstructive Pulmonary Disease
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:40 - Any
Updated:3/20/2019
Start Date:January 9, 2019
End Date:December 30, 2019

Use our guide to learn which trials are right for you!

The proposed study seeks to assess the performance of continuous biosensor data and machine
learning analytics in assessment of health patient status in a pulmonary rehabilitation
program.

It is hypothesized that using continuous physiologic biosensor data and machine learning
analytics to detect changes in physiology may play a role in managing patients in the
pulmonary rehabilitation setting.


Inclusion Criteria:

- Male or female, at least 40 years of age;

- Diagnosis of Chronic Obstructive Pulmonary Disease (COPD);

- Enrolled in the study site's 12-week pulmonary rehabilitation program;

- Capable of completing a 6-minute walk test;

- Willing and able to comply with scheduled protocol procedures and follow up;

- Signed and dated informed consent and HIPAA materials indicating that the patient has
agreed to participate in this study and has been informed of all pertinent aspects of
the trial.

Exclusion Criteria:

- Patient has cognitive or physical limitations that, in the opinion of the
investigator, limit the patient's ability to utilize the System as instructed;

- Patient is actively enrolled in another clinical investigation that, in the opinion of
the investigator, interferes with or compromises either that patient's ability to
participation in this study or the ability for the study to generate results;

- Patients who have implanted defibrillators or pacemakers;

- Patient is allergic to hydrocolloid adhesive;

- Patient does not speak English.
We found this trial at
1
site
Evanston, Illinois 60201
?
mi
from
Evanston, IL
Click here to add this to my saved trials